Related Experiment Videos
Topical atropine and timolol therapy in failed retinal detachment surgery
H K Tewari1, Y R Sharma, R V Azad
1Dr. Rajendra Prasad Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi.
Summary
Topical timolol and atropine did not improve retinal reattachment in failed retinal detachment surgeries without clear breaks. Proliferative vitreoretinopathy did not affect outcomes in this study.
Area of Science:
- Ophthalmology
- Retinal Surgery
- Pharmacology
Background:
- Retinal detachment surgery can fail without identifiable open breaks.
- Proliferative vitreoretinopathy (PVP) is a known complication affecting surgical outcomes.
- Investigating novel therapeutic strategies for refractory retinal detachment is crucial.
Purpose of the Study:
- To evaluate the efficacy of topical timolol monotherapy versus combined topical timolol and atropine for failed retinal detachment surgery.
- To assess treatment outcomes in patients with and without proliferative vitreoretinopathy.
Main Methods:
- A double-blind, randomized, prospective study was conducted.
- Patients with surgically failed retinal detachment and no apparent open break were included.
- Participants were assigned to receive either topical timolol or topical timolol plus atropine.
Main Results:
- No statistically significant difference in retinal reattachment rates was observed between the two treatment groups.
- The presence or absence of proliferative vitreoretinopathy did not significantly alter the outcomes in either group.
Conclusions:
- Combined topical timolol and atropine do not offer a significant advantage over timolol alone for failed retinal detachment surgery.
- Further research may be needed to explore alternative treatments for complex cases of retinal detachment failure.